For instance, GPMVs derived from tumour tissue of BALB/c or C57Bl/6 mice, studded with a breast cancer antigen HER-2 (Patel et al., 2016), GPI-HER-2-PMVs, elicited a strong immune response along with offering protection against tumor challenge. Here, ERBB2 is linked to breast carcinoma.